FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Erwin De Genst

Research Profile

Living Beings

Concepts & Ideas

Chemicals & Drugs

Phenomena

Protein Binding

Procedures

Genes & Molecular Sequences

Amino Acid Sequences

Disorders

Familial Amyloidosis

Co-author Network

Publications

TOP 3
Minkoo Ahn; Erwin De Genst; Christopher M Dobson; Miklos Erdelyi; Gabriele S Kaminski Schierle; Clemens F Kaminski; Janet R Kumita
Analysis of the native structure, stability and aggregation of biotinylated human lysozyme.
Erwin De Genst; Christopher M Dobson
Nanobodies as structural probes of protein misfolding and fibril formation.
Christine L Hagan; Russell J K Johnson; Anne Dhulesia; Mireille Dumoulin; Janice Dumont; Erwin De Genst; John Christodoulou; Carol V Robinson; Christopher M Dobson; Janet R Kumita
A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Erwin De Genst (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Minkoo Ahn; Erwin De Genst; Christopher M Dobson; Miklos Erdelyi; Gabriele S Kaminski Schierle; Clemens F Kaminski; Janet R Kumita
Analysis of the native structure, stability and aggregation of biotinylated human lysozyme.
PloS one 2012;7(11):e50192.
2012: Erwin De Genst; Christopher M Dobson
Nanobodies as structural probes of protein misfolding and fibril formation.
Methods in molecular biology (Clifton, N.J.) 2012;911():533-58.
2010: Christine L Hagan; Russell J K Johnson; Anne Dhulesia; Mireille Dumoulin; Janice Dumont; Erwin De Genst; John Christodoulou; Carol V Robinson; Christopher M Dobson; Janet R Kumita
A non-natural variant of human lysozyme (I59T) mimics the in vitro behaviour of the I56T variant that is responsible for a form of familial amyloidosis.
Protein engineering, design & selection : PEDS 2010;23(7):499-506.
2009: Anneleen Vuchelen; Elizabeth O'Day; Erwin De Genst; Els Pardon; Lode Wyns; Mireille Dumoulin; Christopher M Dobson; John Christodoulou; Shang-Te Danny Hsu
(1)H, (13)C and (15)N assignments of a camelid nanobody directed against human alpha-synuclein.
Biomolecular NMR assignments 2009;3(2):231-3.
2009: Serge Muyldermans; Toya Nath Baral; V Cortez Retamozzo; Patrick De Baetselier; Erwin De Genst; Jörg Kinne; H Leonhardt; Stefan Magez; Viet Khong Nguyen; Hilde Revets; U Rothbauer; Benoit Stijlemans; S Tillib; Ulrich Wernery; Lode Wyns; Gh Hassanzadeh-Ghassabeh; Dirk Saerens
Camelid immunoglobulins and nanobody technology.
Veterinary immunology and immunopathology 2009;128(1-3):178-83.
2008: Pak-Ho Chan; Els Pardon; Linda Menzer; Erwin De Genst; Janet R Kumita; John Christodoulou; Dirk Saerens; Alain Brans; Fabrice Bouillenne; David B Archer; Carol V Robinson; Serge Muyldermans; Alain Matagne; Christina Redfield; Lode Wyns; Christopher M Dobson; Mireille Dumoulin
Engineering a camelid antibody fragment that binds to the active site of human lysozyme and inhibits its conversion into amyloid fibrils.
Biochemistry 2008;47(42):11041-54.
2007: Danuta Wawrzak; Mourad Métioui; Erik Willems; Marijke Hendrickx; Erwin De Genst; Luc Leyns
Wnt3a binds to several sFRPs in the nanomolar range.
Biochemical and biophysical research communications 2007;357(4):1119-23.
2006: Erwin De Genst; Karen Silence; Klaas Decanniere; Katja Conrath; Remy Loris; Jörg Kinne; Serge Muyldermans; Lode Wyns
Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(12):4586-91.
2006: Erwin De Genst; Dirk Saerens; Serge Muyldermans; Katja Conrath
Antibody repertoire development in camelids.
Developmental and comparative immunology 2006;30(1-2):187-98.
2005: Annick Dejaegere; Laurence Choulier; Virginie Lafont; Erwin De Genst; Danièle Altschuh
Variations in antigen-antibody association kinetics as a function of pH and salt concentration: a QSAR and molecular modeling study.
Biochemistry 2005;44(44):14409-18.
2005: Minh-Hoa Dao-Thi; Laurence Van Melderen; Erwin De Genst; Hassan Afif; Lieven Buts; Lode Wyns; Remy Loris
Molecular basis of gyrase poisoning by the addiction toxin CcdB.
Journal of molecular biology 2005;348(5):1091-102.
2005: Erwin De Genst; Karen Silence; Mehdi Arbabi Ghahroudi; Klaas Decanniere; Remy Loris; Jörg Kinne; Lode Wyns; Serge Muyldermans
Strong in vivo maturation compensates for structurally restricted H3 loops in antibody repertoires.
The Journal of biological chemistry 2005;280(14):14114-21.
2005: Julie Bouckaert; Jenny Berglund; Mark Schembri; Erwin De Genst; Lieve Cools; Manfred Wuhrer; Chia-Suei Hung; Jerome S Pinkner; Rikard Slättegård; Andrey V Zavialov; Devapriya Choudhury; Solomon Langermann; Scott J Hultgren; Lode Wyns; Per Klemm; Stefan Oscarson; Stefan D Knight; Henri De Greve
Receptor binding studies disclose a novel class of high-affinity inhibitors of the Escherichia coli FimH adhesin.
Molecular microbiology 2005;55(2):441-55.
2004: Erwin De Genst; Fabian Handelberg; Annemieke Van Meirhaeghe; Samuel Vynck; Remy Loris; Lode Wyns; Serge Muyldermans
Chemical basis for the affinity maturation of a camel single domain antibody.
The Journal of biological chemistry 2004;279(51):53593-601.
2004: Minh-Hoa Dao-Thi; Laurence Van Melderen; Erwin De Genst; Lieven Buts; An Ranquin; Lode Wyns; Remy Loris
Crystallization of CcdB in complex with a GyrA fragment.
Acta crystallographica. Section D, Biological crystallography 2004;60(Pt 6):1132-4.
2003: Lieven Buts; Julie Bouckaert; Erwin De Genst; Remy Loris; Stefan Oscarson; Martina Lahmann; Joris Messens; Elke Brosens; Lode Wyns; Henri De Greve
The fimbrial adhesin F17-G of enterotoxigenic Escherichia coli has an immunoglobulin-like lectin domain that binds N-acetylglucosamine.
Molecular microbiology 2003;49(3):705-15.
2003: Lieven Buts; Remy Loris; Erwin De Genst; Stefan Oscarson; Martina Lahmann; Joris Messens; Elke Brosens; Lode Wyns; Henri De Greve; Julie Bouckaert
Solving the phase problem for carbohydrate-binding proteins using selenium derivatives of their ligands: a case study involving the bacterial F17-G adhesin.
Acta crystallographica. Section D, Biological crystallography 2003;59(Pt 6):1012-5.
2002: Erwin De Genst; Daphne Areskoug; Klaas Decanniere; Serge Muyldermans; Karl Andersson
Kinetic and affinity predictions of a protein-protein interaction using multivariate experimental design.
The Journal of biological chemistry 2002;277(33):29897-907.
1998: TR Transue; Erwin De Genst; Mehdi Arbabi Ghahroudi; Lode Wyns; Serge Muyldermans
Camel single-domain antibody inhibits enzyme by mimicking carbohydrate substrate.
Proteins 1998;32(4):515-22.
1998: Marc Lauwereys; M Arbabi Ghahroudi; Aline Desmyter; Jörg Kinne; W Hölzer; Erwin De Genst; Lode Wyns; Serge Muyldermans
Potent enzyme inhibitors derived from dromedary heavy-chain antibodies.
The EMBO journal 1998;17(13):3512-20.